MYX mayne pharma group limited

Are we at the bottom, page-248

  1. 1,530 Posts.
    lightbulb Created with Sketch. 269
    Why doesn’t Richards talk up $200 m + Revenue
    get a mention now upon approval.
    He did when requiring shareholders approval to
    give go ahead to agreement with Mithra.
    Investors understand $$$$ and potentially profitable
    figures more than non toxic, weight loss, bio degradability etc. They may be beneficial but $$ predictions are preferable. Even stating Company could soon be debt free with this approval would see
    accumulation and a re rating. Back into ASX 200.
    Positive comments.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.95
Change
-0.200(3.88%)
Mkt cap ! $402.1M
Open High Low Value Volume
$5.05 $5.09 $4.93 $824.9K 165.3K

Buyers (Bids)

No. Vol. Price($)
1 16429 $4.95
 

Sellers (Offers)

Price($) Vol. No.
$5.08 5000 1
View Market Depth
Last trade - 16.10pm 31/07/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.